• Home
  • About
  • Investments
  • Press
  • Contact
Lucas Venture Group

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

by dakota@oneupdigitalmarketing.com | Aug 10, 2022 | Uncategorized | 0 comments

Recent Posts

  • Women’s-Specific Basketball Sneaker Brand Moolah Kicks Launches Girls-Specific Design
  • Women Basketball Players Have Been Stuck Playing in Men’s Shoes
  • TransAstra claims NASA contract for debris capture bag
  • TransAstra Wins Space Force Phase 2 Contract for Development of Groundbreaking Turn Key Telescope Observatory System
  • Finicast bags $12.8m to revolutionize enterprise planning

Recent Comments

No comments to show.

© 2023 Lucas Venture Group. All Rights Reserved.

Privacy Policy — Terms Of Service 

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Lucas Venture Group Logo
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Privacy Policy — Terms Of Service 

Google Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!